Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theraflu Night Powder for URTI Symptoms
NCT02730364Phase 3Withdrawn
- Sponsor
- GSK
- Start
- Feb 2017
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acetaminophen, phenylephrine, pheniramine, ascorbic acid in upper respiratory tract infection (URI), sponsored by GSK. Planned start Feb 2017; status: withdrawn.
02
Drugs
acetaminophenphenylephrinepheniramineascorbic acid
03
Conditions
upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT02730364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730364.